Literature DB >> 24829683

Seroprevalence of Hepatitis A among Students Enrolled in Tehran University of Medical Sciences during 2011.

Anahita Rabiee1, Sina Nikayin1, Seyed Reza Hashemi2, Mostafa Mohaghegh2, Marzieh Amini1, Roozbeh Rabiee3, Shahin Merat1.   

Abstract

BACKGROUND: Hepatitis A is often asymptomatic in children, however it can become a serious disease in adults. For countries that do not have a universal vaccination strategy targeted vaccination for high risk groups is recommended. Health workers could be at a higher risk of infection with hepatitis A virus (HAV) compared to the general population. The aim of this study is to investigate the seroprevalence of hepatitis A among enrolled students in Tehran University of Medical Sciences in 2011.
METHODS: This study included all students enrolled in Tehran University of Medical Sciences during 2011. We checked serum samples for anti-HAV antibody and participants completed a simple questionnaire.
RESULTS: SFrom 1864 health sciences students enrolled in Tehran University of Medical Sciences, 1813 samples were analyzed for anti-HAV IgG antibody. The results showed that 970 (53.5%) were seronegative, 722 (39.8%) were seropositive, and 121 (6.7%) were equivocal. There were significantly higher seropositive results for males (54%) compared to females (37%; RR = 1.46; 95% CI: 1.31-1.62).
CONCLUSION: The seroprevalence of HAV among enrolled medical science students is considerably lower than previous reports from Iran. Targeted vaccination for health sciences students prior to exposure should be seriously considered.

Entities:  

Keywords:  Hepatitis A; Seroepidemiologic Studies; Vaccination

Year:  2013        PMID: 24829683      PMCID: PMC3990182     

Source DB:  PubMed          Journal:  Middle East J Dig Dis        ISSN: 2008-5230


  24 in total

1.  Age-specific seroprevalence of hepatitis A in Sari, northern Islamic Republic of Iran.

Authors:  S Alian; A Ajami; R Ghasemian; D Yadegarinia
Journal:  East Mediterr Health J       Date:  2011-10       Impact factor: 1.628

2.  Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study.

Authors:  Shahin Merat; Houri Rezvan; Mehdi Nouraie; Hassan Abolghasemi; Raika Jamali; Sedigheh Amini-Kafiabad; Mahtab Maghsudlu; Akram Pourshams; Reza Malekzadeh
Journal:  Arch Iran Med       Date:  2010-03       Impact factor: 1.354

3.  Changing epidemiology of hepatitis A infection in Izmir, Turkey.

Authors:  Zafer Kurugol; Asli Aslan; Ebru Turkoglu; Guldane Koturoglu
Journal:  Vaccine       Date:  2011-07-18       Impact factor: 3.641

Review 4.  New challenges in viral hepatitis.

Authors:  David Thomas; Fabien Zoulim
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

5.  Prevalence and risk factors of hepatitis A among blood donors in Qazvin, central Iran.

Authors:  H Ramezani; S H Bozorgi; M Nooranipour; A Mostajeri; H Kargar-Fard; S Molaverdikhani; A Mazdaki; S M Alavian
Journal:  Singapore Med J       Date:  2011-02       Impact factor: 1.858

6.  The cost-effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates.

Authors:  R J Jacobs; H S Margolis; P J Coleman
Journal:  Arch Pediatr Adolesc Med       Date:  2000-08

Review 7.  Risk groups for hepatitis A virus infection.

Authors:  Elisabetta Franco; Cristina Giambi; Rita Ialacci; Rosa C Coppola; Alessandro R Zanetti
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

8.  Changing patterns of hepatitis A prevalence within the Saudi population over the last 18 years.

Authors:  Faleh Al Faleh; Suliman Al Shehri; Saleh Al Ansari; Mohammed Al Jeffri; Yaqoub Al Mazrou; Ahmad Shaffi; Ayman-A Abdo
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

9.   Clinical course and management of acute hepatitis A infection in adults.

Authors:  Ileana Mackinney-Novelo; Josué Barahona-Garrido; Fátima Castillo-Albarran; Jean J Santiago-Hernández; Nahum Méndez-Sánchez; Misael Uribe; Norberto Chávez-Tapia
Journal:  Ann Hepatol       Date:  2012 Sep-Oct       Impact factor: 2.400

Review 10.  Challenges to mapping the health risk of hepatitis A virus infection.

Authors:  Khayriyyah Mohd Hanafiah; Kathryn H Jacobsen; Steven T Wiersma
Journal:  Int J Health Geogr       Date:  2011-10-18       Impact factor: 3.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.